Kinsella JM , Laidlaw HA , Tang T , Harvey J , Sutherland C , Ashford ML .

068692 Wellcome Trust , WT068692 Wellcome Trust , Wellcome Trust

	Figure 1. Structure of BVT.12777 ([2-(hydrazinoiminomethyl)-hydrazino] acetic acid)
	Figure 2. BVT.12777 activates a tolbutamide-sensitive K+ current A, the upper trace shows a current clamp recording of a CRI-G1 cell following dialysis with a 5 mM ATP-containing solution. In this and subsequent current clamp figures the trace begins approximately 5 min after formation of the whole-cell configuration. Application of BVT.12777 (100 μM) for the time indicated hyperpolarized the cell from -50 mV to -76 mV, an action readily reversed by tolbutamide (100 μM), which returned membrane potential to -54 mV. Washout of all drugs from the bath resulted in a membrane potential of -70 mV, indicating the lack of reversibility of BVT.12777. The lower plot is the current-voltage relationship for the voltage clamped currents. Cells were voltage clamped at -50 mV and 10 mV steps of 100 ms duration were applied every 200 ms (range -120 to -30 mV). BVT.12777 increased the membrane conductance relative to control and tolbutamide reversed this BVT.12777-induced conductance increase with a reversal potential of -78 mV. B, cell-attached recording from a CRI-G1 cell, at 10 mV applied to the recording pipette. Single channel openings are shown as downward deflections. Addition of 100 μM BVT.12777 induced an increase in channel activity (Nf.Po) from 0.17 in control to 0.31, and 1.25 at 10 and 20 minutes respectively, after BVT addition. Application of 100 μM tolbutamide induced a substantial inhibition of activity (to 0.02), which was reversed on washout of all drugs, with activity increasing to 0.74. The symbol C refers to the closed state of the channel in this and subsequent figures. C, diary plot of Nf.Po against time from cell-attached experiments in the presence and absence of BVT.12777, where channel activity was calculated every 2 minutes. Each point is the mean of 4–7 separate determinations.
	Figure 3. BVT.12777 activates KATP channels in inside-out patches Continuous single channel currents recorded from an inside-out patch at a holding potential of -40 mV. Application of 100 μM MgATP reversibly inhibited channel activity by >90%, demonstrating KATP identity. Addition of 100 μM BVT.12777, in the presence of 100 μM MgATP to the cytoplasmic aspect of the patch resulted in KATP channel activation. Nf.Po values were 2.96 (control, after first MgATP challenge), and 0.25 in the presence of MgATP, which increased to 0.72, 1.06 and 2.74 at 5, 10 and 20 minutes respectively, after BVT.12777 addition.
	Figure 4. Wortmannin does not inhibit BVT.12777 activation of KATP A, current clamp record of a CRI-G1 cell dialysed with 5 mM MgATP, following exposure of cells to 10 nM wortmannin for 15–20 minutes. Application of BVT.12777 (200 μM), in the continued presence of wortmannin hyperpolarized the cell from -46 to -77 mV. Tolbutamide (100 μM), applied after the BVT-induced hyperpolarization, recovered the membrane potential (to -40 mV). B, cell-attached recordings from CRI-G1 cells, following exposure of cells to 10 nM wortmannin for 15–20 minutes. Upper trace; in the continued presence of wortmannin, Nf.Po was 0.01 and 0.03 after 5 and 30 minutes respectively. Lower trace, application of BVT.12777 (100 μM) to cell-attached recording in the presence of 10 nM wortmannin resulted in KATP activation, with Nf.Po values of 0.01, 0.12 and 0.27 prior to, and 10 and 30 minutes after, BVT.12777, respectively. Addition of 100 nM wortmannin did not inhibit channel activity.
	Figure 5. Phalloidin prevents BVT.12777 activation of KATP A, current clamp record of a CRI-G1 cell dialysed with 5 mM MgATP and 10 μM phalloidin. Application of BVT.12777 (200 μM) had no effect on the membrane potential of the cell (-41 mV) in the presence of phalloidin. B, continuous single channel currents recorded from an inside-out patch at a holding potential of -40 mV. Application of 100 μM MgATP reversibly inhibited Nf.Po from 1.25 to 0.02. Addition of 10 μM phalloidin and subsequently 100 μM BVT.12777, in the presence of 100 μM MgATP, to the cytoplasmic aspect of the patch resulted in no effect on KATP, with Nf.Po values of 0.01 and 0.03 respectively. C, current clamp record of a CRI-G1 cell dialysed with 5 mM MgATP and 10 μM phalloidin. Application of diazoxide (200 μM) induced rapid cell membrane hyperpolarization, from -55 to -72 mV, an action reversed (to -45 mV) by tolbutamide (100 μM).
	Figure 6. BVT.12777 disrupts the actin cytoskeleton A, images of rhodamine-conjugated phalloidin fluorescence in CRI-G1 cells in control conditions and following incubation with leptin (10 nM), BVT.12777 (100 μM) or diazoxide (200 μM) for 30 minutes. All panels show representative X-Y images. Note the marked reduction in phalloidin staining in cells pre-treated with leptin or BVT.12777, and not diazoxide. Scale bars are 50 μm. B, histogram comparing the normalised fluorescence intensity relative to control in the membrane periphery of randomly selected CRI-G1 cells for each condition; (control (n = 13; cells = 195), 10 nM leptin (n = 6; cells = 90), BVT.12777 (n = 6; cells = 90) and 200 μM diazoxide (n = 4, cells = 60). Error bars indicate s.e.m. and * significance of P < 0.001.

Ahima, Leptin. 2000, Pubmed

Ahima, Leptin. 2000, Pubmed
Alessi, PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. 1995, Pubmed
Ashcroft, ATP-sensitive K+ channels and insulin secretion: their role in health and disease. 1999, Pubmed
Babenko, A view of sur/KIR6.X, KATP channels. 1998, Pubmed
Babenko, Pharmaco-topology of sulfonylurea receptors. Separate domains of the regulatory subunits of K(ATP) channel isoforms are required for selective interaction with K(+) channel openers. 2000, Pubmed
Carrington, Five new insulin-producing cell lines with differing secretory properties. 1986, Pubmed
Cooper, Effects of cytochalasin and phalloidin on actin. 1987, Pubmed
Dabrowski, The novel diazoxide analog 3-isopropylamino-7-methoxy-4H-1,2,4-benzothiadiazine 1,1-dioxide is a selective Kir6.2/SUR1 channel opener. 2002, Pubmed , Xenbase
Davies, Specificity and mechanism of action of some commonly used protein kinase inhibitors. 2000, Pubmed
Dunne, Ions, genes and insulin release: from basic science to clinical disease. Based on the 1998 R. D. Lawrence Lecture. 2000, Pubmed
Gribble, The essential role of the Walker A motifs of SUR1 in K-ATP channel activation by Mg-ADP and diazoxide. 1997, Pubmed , Xenbase
Gribble, Pharmacological modulation of K(ATP) channels. 2002, Pubmed
Gribble, Properties of cloned ATP-sensitive K+ currents expressed in Xenopus oocytes. 1997, Pubmed , Xenbase
Harvey, Insulin occludes leptin activation of ATP-sensitive K+ channels in rat CRI-G1 insulin secreting cells. 1998, Pubmed
Harvey, Essential role of phosphoinositide 3-kinase in leptin-induced K(ATP) channel activation in the rat CRI-G1 insulinoma cell line. 2000, Pubmed
Harvey, Dual actions of the metabolic inhibitor, sodium azide on K(ATP) channel currents in the rat CRI-G1 insulinoma cell line. 1999, Pubmed
Harvey, Leptin activation of ATP-sensitive K+ (KATP) channels in rat CRI-G1 insulinoma cells involves disruption of the actin cytoskeleton. 2000, Pubmed
Harvey, Leptin activates ATP-sensitive potassium channels in the rat insulin-secreting cell line, CRI-G1. 1997, Pubmed
Janmey, Phosphoinositides and calcium as regulators of cellular actin assembly and disassembly. 1994, Pubmed
Janmey, The cytoskeleton and cell signaling: component localization and mechanical coupling. 1998, Pubmed
Kieffer, The adipoinsular axis: effects of leptin on pancreatic beta-cells. 2000, Pubmed
Kieffer, Leptin suppression of insulin secretion by the activation of ATP-sensitive K+ channels in pancreatic beta-cells. 1997, Pubmed
Kozlowski, Dual effects of diazoxide on ATP-K+ currents recorded from an insulin-secreting cell line. 1989, Pubmed
Lawson, Potassium channel openers as potential therapeutic weapons in ion channel disease. 2000, Pubmed
Lazar, Mitogen-activated protein kinase kinase inhibition does not block the stimulation of glucose utilization by insulin. 1995, Pubmed
Lee, Glucose-receptive neurones in the rat ventromedial hypothalamus express KATP channels composed of Kir6.1 and SUR1 subunits. 1999, Pubmed
Lee, Characterization of an ATP-modulated large conductance Ca(2+)-activated K+ channel present in rat cortical neurones. 1995, Pubmed
Mannhold, KATP channel openers: structure-activity relationships and therapeutic potential. 2004, Pubmed
McKay, Sensitivity of Kir6.2-SUR1 currents, in the absence and presence of sodium azide, to the K(ATP) channel inhibitors, ciclazindol and englitazone. 2000, Pubmed , Xenbase
Meglasson, Antihyperglycemic action of guanidinoalkanoic acids: 3-guanidinopropionic acid ameliorates hyperglycemia in diabetic KKAy and C57BL6Job/ob mice and increases glucose disappearance in rhesus monkeys. 1993, Pubmed
Miki, ATP-sensitive K+ channels in the hypothalamus are essential for the maintenance of glucose homeostasis. 2001, Pubmed
Niswender, Insulin and leptin revisited: adiposity signals with overlapping physiological and intracellular signaling capabilities. 2003, Pubmed
Pollard, Cellular motility driven by assembly and disassembly of actin filaments. 2003, Pubmed
Proks, Sulfonylurea stimulation of insulin secretion. 2002, Pubmed
Rorsman, The pancreatic beta-cell as a fuel sensor: an electrophysiologist's viewpoint. 1997, Pubmed
Schuppe-Koistinen, Molecular profiling of hepatotoxicity induced by a aminoguanidine carboxylate in the rat: gene expression profiling. 2002, Pubmed
Seino, ATP-sensitive potassium channels: a model of heteromultimeric potassium channel/receptor assemblies. 1999, Pubmed
Spanswick, Leptin inhibits hypothalamic neurons by activation of ATP-sensitive potassium channels. 1997, Pubmed
Sturgess, Effects of sulphonylureas and diazoxide on insulin secretion and nucleotide-sensitive channels in an insulin-secreting cell line. 1988, Pubmed
Sweeney, Leptin signalling. 2002, Pubmed
Takahashi, Leptin induces mitogen-activated protein kinase-dependent proliferation of C3H10T1/2 cells. 1997, Pubmed
Tanabe, Leptin induces proliferation of pancreatic beta cell line MIN6 through activation of mitogen-activated protein kinase. 1997, Pubmed
Terzic, Actin microfilament disrupters enhance K(ATP) channel opening in patches from guinea-pig cardiomyocytes. 1996, Pubmed
Vaillancourt, Synthesis and biological activity of aminoguanidine and diaminoguanidine analogues of the antidiabetic/antiobesity agent 3-guanidinopropionic acid. 2001, Pubmed
Wang, GABA(A)-receptor-associated protein links GABA(A) receptors and the cytoskeleton. 1999, Pubmed
Wieland, Amatoxins, phallotoxins, phallolysin, and antamanide: the biologically active components of poisonous Amanita mushrooms. 1978, Pubmed